Riluzole
CAS 1744-22-5
Overview
Riluzole is a medication used to treat amyotrophic lateral sclerosis. Riluzole delays the onset of ventilator-dependence or tracheostomy in some people and may increase survival by two to three months. Riluzole is available in tablet and liquid form
Anant Labs manufacture and furnish high quality Riluzole impurities for global markets. Our Riluzole EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
CAS1744-22-5
Mol. FormulaC8H5F3N2OS
Mol. Weight234.202 g/mol
IUPAC6-(trifluoromethoxy)-1,3-benzothiazol-2-amine
SMILESC1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N
InChIInChI=1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13)
InChI KeyFTALBRSUTCGOEG-UHFFFAOYSA-N
Note: We are upgrading our system, Cat No will change.
Synonyms
riluzole1744-22-5Rilutek2-Amino-6-(trifluoromethoxy)benzothiazole6-(trifluoromethoxy)-1,3-benzothiazol-2-amineRP-54274RiluzolRiluzolum2-amino-6-trifluoromethoxybenzothiazole2-Benzothiazolamine, 6-(trifluoromethoxy)-
